FAIRFIELD, Conn.----IMS Health , the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced third-quarter 2006 revenue of $482.7 million, up 12 percent , compared with revenue of $432.8 million for the third quarter of 2005.
JERUSALEM----Teva Pharmaceutical Industries Ltd. announced today that Israel Makov, 67, has announced his plans to retire as President and CEO during the course of 2007. Shlomo Yanai, 55, will join the company as President and CEO Designate during the first part of 2007.
Aprimo, Incorporated, the global leader in Enterprise Marketing Management (EMM) software, today announced the winners of the Aprimo Excellence (APEX) Awards, annual awards that recognize outstanding achievement in the use of the Aprimo Marketing(TM) suite to improve the precision, discipline and performance of marketing. The winners were honored last night during the APEX Awards presentation at
SYSTECH International, the pharmaceutical industry's premier provider of packaging efficiency and product safety solutions, today announced that its TIPS Serialized Product Tracking solution has been selected by AstraZeneca as part of a broad global initiative that addresses authentication and combats counterfeiting of pharmaceutical drugs.
Nielsen BuzzMetrics, the global measurementstandard in consumer-generated media, today announced that ForresterResearch cited Nielsen BuzzMetrics as an industry 'leader' in its recentevaluation of brand monitoring services.
Nielsen BuzzMetrics, the global measurement standard in consumer-generated media, today announced that Forrester Research cited Nielsen BuzzMetrics as an industry "leader" in its recent evaluation of brand monitoring services.
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, today announced that two senior members of its Sales Practice will present a session at the Sales Training Summit hosted by the Center for Business Intelligence to be held on October 19-20, 2006, at the Marriott Philadelphia West in West Conshohocken, Pennsylvania.
NORCROSS, Ga.----Auriga Laboratories, Inc. , a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, today announced that equity analysis firm EquityNet Research has initiated paid research coverage of the Company with a detailed report that recommends a "Buy" rating, and projects a 12-month share